Frontiers in Pharmacology | Renal Pharmacology

Original Research

Published on 19 Jun 2024

Assessment of the safety of Roxadustat for cardiovascular events in chronic kidney disease-related anemia using meta-analysis and bioinformatics

in Renal Pharmacology

Xiangmeng Li
Shimin Jiang
Xia Gu
Xiaojing Liu
Shunlai Shang
Jiao Zhang
Keying Pang
Wenge Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1380326

3,333 views
5 citations

Original Research

Published on 12 Jun 2024

SGLT2i treatment during AKI and its association with major adverse kidney events

in Renal Pharmacology

Luz Alcantar-Vallin
Jose J. Zaragoza
Bladimir Díaz-Villavicencio
Karla Hernandez-Morales
Jahir R. Camacho-Guerrero
Miguel A. Perez-Venegas
Edgar J. Carmona-Morales
Alexa N. Oseguera-Gonzalez
Cesar Murguia-Soto
Gael Chávez-Alonso

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356991

5,609 views
3 citations

Original Research

Published on 10 Jun 2024

Relationship between low molecular weight heparin calcium therapy and prognosis in severe acute kidney injury in sepsis: Mendelian randomized analysis and retrospective study

in Renal Pharmacology

Jian-Chun Li
Shi-Tao Huang
Fei Feng
Lin-Jun Wang
Ting-Ting Chen
Min Li
Li-Ping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389354

3,944 views
1 citation

Review

Published on 07 Jun 2024

Targeting pyruvate kinase M2 for the treatment of kidney disease

in Renal Pharmacology

Dan-Qian Chen
Jin Han
Hui Liu
Kai Feng
Ping Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376252

6,144 views
10 citations

Original Research

Published on 07 Jun 2024

Myricitrin inhibited ferritinophagy-mediated ferroptosis in cisplatin-induced human renal tubular epithelial cell injury

in Renal Pharmacology

Jiawen Lin
Yangyang Zhang
Hui Guan
Shuping Li
Yuan Sui
Ling Hong
Zhihua Zheng
Mingcheng Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372094

4,222 views
9 citations

Systematic Review

Published on 30 May 2024

Pooled-analysis of tadalafil and tamsulosin for ureteral calculi

in Renal Pharmacology

Fengze Sun
Hongquan Liu
Gang Wu
Ming Liu
Shangjing Liu
Lin Wang
Qingsong Zou
Yuanshan Cui
Jitao Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1351312

3,832 views

Original Research

Published on 30 May 2024

Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis

in Renal Pharmacology

Emiko Otsuka
Mineaki Kitamura
Satoshi Funakoshi
Hiroshi Mukae
Tomoya Nishino

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1362242

3,690 views
6 citations

Original Research

Published on 23 May 2024

Computational drug discovery approaches identify mebendazole as a candidate treatment for autosomal dominant polycystic kidney disease

in Renal Pharmacology

Philip W. Brownjohn
Azedine Zoufir
Daniel J. O’Donovan
Saatviga Sudhahar
Alexander Syme
Rosemary Huckvale
John R. Porter
Hester Bange
Jane Brennan
Neil T. Thompson

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397864

4,886 views
2 citations

Original Research

Published on 23 May 2024

Mortality prediction and influencing factors for intensive care unit patients with acute tubular necrosis: random survival forest and cox regression analysis

in Renal Pharmacology

Jinping Zeng
Min Zhang
Jiaolan Du
Junde Han
Qin Song
Ting Duan
Jun Yang
Yinyin Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361923

2,012 views
2 citations

Original Research

Published on 22 May 2024

Pharmacological targets of SGLT2 inhibitors on IgA nephropathy and membranous nephropathy: a mendelian randomization study

in Renal Pharmacology

Xin Lv
Yan Shang
Yong Ning
Weimin Yu
Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399881

7,047 views
7 citations

Original Research

Published on 21 May 2024

Nimbidiol protects from renal injury by alleviating redox imbalance in diabetic mice

in Renal Pharmacology

Subir Kumar Juin
Sathnur Pushpakumar
Utpal Sen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369408

2,395 views
1 citation

Review

Published on 21 May 2024

Effects of cell-free DNA on kidney disease and intervention strategies

in Renal Pharmacology

Mingying Zhang
Yubin Cai
Xiaoze Zhong
Weijun Liu
Yuan Lin
Zhanyi Qiu
Ruihuang Liang
Huibo Wei
Kefei Wu
Qinghua Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377874

2,825 views
4 citations

Review

Published on 20 May 2024

Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis

in Renal Pharmacology

Weijun Liu
Guanyuan Tian
Chao Chen
Mingying Zhang
Zhanmao Chen
Tietao Chen
Zhibin Lin
Wuzhong Wu
Yiqaing Wu
Kefei Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378384

3,880 views
1 citation

Review

Published on 07 May 2024

Mechanism of tacrolimus in the treatment of lupus nephritis

in Renal Pharmacology

Ming Wang
Jing Zhou
Qiyan Niu
Hongyue Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1331800

7,747 views
12 citations

Original Research

Published on 01 May 2024

Pre-operative maintenance of angiotensin-converting enzyme inhibitors is not associated with acute kidney injury in cardiac surgery patients with cardio-pulmonary bypass: a propensity-matched multicentric analysis

in Renal Pharmacology

Pierre Guilleminot
Stefan Andrei
Maxime Nguyen
Osama Abou-Arab
Emmanuel Besnier
Belaid Bouhemad
Pierre-Grégoire Guinot
Collaborator study group
Jean-Baptiste Anciaux
Annouck Appriou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1343647

3,161 views
2 citations

Original Research

Published on 26 Apr 2024

A Chinese patent medicine’s long-term efficacy on non-dialysis patients with CKD stages 3–5: a retrospective cohort study

in Renal Pharmacology

Hui-Fen Chen
Yu-Jie Lin
Yan Han
Xian-Long Zhang
Ruo-Bing Wang
Jun-Hui Chen
Ying Pi
Li-Zhe Fu
Fang Tang
Xi-Na Jie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379338

5,529 views
1 citation